Sunday, April 09, 2006
Merck ex-CEO denies hiding Vioxx (Vioxx lawyer) data from FDA
Merck ex-CEO denies hiding Vioxx data from FDA
ATLANTIC CITY, New Jersey (Reuters) - Merck & Co.'s MRK.N former chief executive denied the company hid data on Vioxx from regulators as he took the stand on Thursday before a jury that will decide whether to award punitive damages to a man who said the painkiller caused his heart attack.
Source: go.reuters.com
In defense of Vioxx
The former CEO of Merck & Co. on Thursday denied a plaintiff lawyer's suggestions that the drugmaker withheld information about the safety of its painkiller Vioxx from the Food and Drug Administration.
Source: www.sanluisobispo.com
Vioxx user awarded $4.5M in split verdict
A retired Park Ridge insurance salesman, a long-term user of the painkiller Vioxx, was awarded $4.5 million in damages Wednesday by a jury that found Merck & Co. liable for his heart attack.
Source: www.northjersey.com
Ex-CEO denies Merck withheld Vioxx data
ATLANTIC CITY, N.J. The former CEO of Merck & Co. on Thursday denied a plaintiff lawyer's suggestions that the drug maker withheld information about the safety of its painkiller Vioxx from the Food and Drug Administration.
Source: feeds.sun-sentinel.com
Merck's Gilmartin to Testify After $4.5 Million Vioxx Verdict
April 6 (Bloomberg) -- Merck & Co.'s former Chief Executive Officer Raymond Gilmartin will testify today to a jury weighing punitive damages after awarding $4.5 million to a 77-year-old man who blamed the company's painkiller Vioxx for his heart attack.
Source: www.bloomberg.com
Jury reaches verdict in Merck Vioxx trial
A jury reached a verdict in the New Jersey trial against Merck & Co. and its liability over the withdrawn painkiller Vioxx.
Source: news.yahoo.com
U.S. stocks lose ground; Merck hurt by Vioxx setback
NEW YORK (MarketWatch) -- U.S. stocks moved lower in midday trading Thursday after retailers booked mostly lackluster sales in March, with Merck & Co. weighing on the Dow Jones Industrial Average as its shares tumbled following a legal setback over its Vioxx painkiller.
Source: www.marketwatch.com
Testimony Comes to End in Vioxx Case
A former official from the Food and Drug Administration testified Friday that Merck & Company properly submitted all information on its Vioxx drug to regulators.
Source: www.nytimes.com
Merck denied Vioxx case punitive phase dismissal
ATLANTIC CITY, New Jersey (Reuters) - Merck & Co. Inc. MRK.N asked a judge on Friday to dismiss the punitive phase of this Vioxx liability case, arguing that the plaintiff's attorneys had not presented evidence that showed the drugmaker hid data on its painkiller from regulators, but the motion was denied.
Source: go.reuters.com
